Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease congestive heart failure
Phenotype C0011860|type 2 diabetes
Sentences 5
PubMedID- 25929426 Background: the aim of the present study was to assess the risk of overall mortality, coronary artery disease (cad), and congestive heart failure (chf) in patients with type 2 diabetes mellitus (t2dm) treated with metformin (mf) and an additional antidiabetic agent.
PubMedID- 20204067 Tzds are known to induce salt and water retention, which exacerbate the risk of congestive heart failure in patients with type 2 diabetes.
PubMedID- 21671441 Thiazolidinediones and the risk of incident congestive heart failure among patients with type 2 diabetes mellitus.
PubMedID- 21415101 Objective: to determine the comparative effects of the thiazolidinediones (rosiglitazone and pioglitazone) on myocardial infarction, congestive heart failure, and mortality in patients with type 2 diabetes.
PubMedID- 21205120 Thiazolidinediones and congestive heart failure in veterans with type 2 diabetes.

Page: 1